Comparative study of kanamycin sulphate microparticles and nanoparticles for intramuscular administration: preparation in vitro release and preliminary in vivo evaluation

References

• Aderem A, Underhill DM. Mechanisms of phagocytosis in macrophages. Annu Rev Immunol, 1999;17:593–623.
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev, 2009;61:428–37.
   PubMed Web of Science ®Google Scholar
• Allison SD. Analysis of initial burst in PLGA microparticles. Expert Opin Drug Deliv, 2008;5:615–28.
   PubMed Web of Science ®Google Scholar
• Asadi A. Streptomycin-loaded PLGA-alginate nanoparticles: Preparation, characterisation, and assessment. Appl Nanosci, 2014;4:455–60.
   Web of Science ®Google Scholar
• Benet LZ, Bccatelli F, Oprea TI. BDDCS applied to over 900 drugs. AAPS J, 2011;13:519–47.
   PubMed Web of Science ®Google Scholar
• Blanchaert B, Jorge PP, Jankovics P, et al. Assay of kanamycin by HPLC with direct UV detection. Chromatographia, 2013;21:1505–51.
   Web of Science ®Google Scholar
• Cambronero-Rojas A, Torres-Vergara P, Godoy R, et al. Capreomycin oleate microparticles for intramuscular administration: Preparation, in vitro release and preliminary in vivo evaluation. J Control Release, 2015;209:229–37.
   PubMed Web of Science ®Google Scholar
• Damge C, Michel C, Aprahamian M, et al. Nanocapsules as carriers for oral peptide delivery. J Control Release, 1990;13:233–9.
   Web of Science ®Google Scholar
• Dijkstra JA, Altena VR, Akkerman OW, et al. Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis. Int J Antimicrob Agents, 2015;3:332–7.
   Web of Science ®Google Scholar
• Doluisio JT, Dittert LW, LaPiana JC. Pharmacokinetics of kanamycin following intramuscular administration. J Pharmacokinet Biopharm, 1973;1:253–65.
   Google Scholar
• Edson RS, Terrell CL. The aminoglycosides. Mayo Clin Proc, 1999;74:519–28.
   PubMed Web of Science ®Google Scholar
• Fonseca C, Simoes S, Gaspar R. Paclitaxel-loaded PLGA nanoparticles: Preparation, physicochemical characterization and in vitro anti-tumoral activity. J Control Release, 2002;83:273–86.
   PubMed Web of Science ®Google Scholar
• Gasparini G, Holdich RG, Kosvintsev SR. PLGA particle production for water-soluble drug encapsulation: Degradation and release behaviour. Colloids Surf B Biointerfaces, 2010;75:557–64.
   PubMed Web of Science ®Google Scholar
• Giovagnoli S, Blasi P, Schoubben A, et al. Preparation of large porous biodegradable microspheres by using a simple double-emulsion method for capreomycin sulfate pulmonary delivery. Int J Pharm, 2007;333:103–11.
   PubMed Web of Science ®Google Scholar
• Grabowski N, Hillaireau H, Vergnaud H, et al. Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells. Int J Pharm, 2013;454:686–94.
   PubMed Web of Science ®Google Scholar
• Hardy CL, Lemasurier JS, Mohamud R. Differential uptake of nanoparticles and microparticles by pulmonary APC subsets induces discrete immunological imprints. J Immunol, 2013;191:5278–90.
   PubMed Web of Science ®Google Scholar
• Henley CM, Weatherly RA, Ou CN, et al. Pharmacokinetics of kanamycin in the developing rat. Hear Res, 1996;99:85–90.
   PubMed Web of Science ®Google Scholar
• Jager DP, Altena VR. Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis. Int J Tuberc Lung Dis, 2002;6:622–7.
   PubMed Web of Science ®Google Scholar
• Jintian H, Zhou Z, Fan Y, et al. Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method. J Microencapsul, 2011;28:763–70.
   PubMed Web of Science ®Google Scholar
• Kim IS, Lee SK, Park YM, et al. Physicochemical characterization of poly(L-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm, 2015;298:255–62.
   Web of Science ®Google Scholar
• Kreuter J. Nanoparticles and microparticles for drug and vaccine delivery. J Anat, 1996;189:503–5.
   PubMed Web of Science ®Google Scholar
• Lopez-Cervantes M, Escobar-Chavez JJ, Casas-Alancaster N, et al. Development and characterisation of a transdermal patch and an emulgel containing kanamycin intended to be used in the treatment of mycetoma caused by Actinomadura madurae. Drug Dev Ind Pharm, 2009;35:1511–21.
   PubMed Web of Science ®Google Scholar
• Manion JR, Cape SP, McAdams DH, et al. Inhalable antibiotics manufactured through use of near-critical or supercritical fluids. Aerosol Sci Tech, 2012;46:403–10.
   Web of Science ®Google Scholar
• Mao S, Xu J, Cai C. Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres. Int J Pharm, 2007;334:137–48.
   PubMed Web of Science ®Google Scholar
• McCall RL, Sirianni RW. PLGA nanoparticles formed by single- or double-emulsion with vitamin E-TPGS. J Vis Exp, 2013;82:15–25.
   Google Scholar
• Mingeot-Leclercq MP, Tulkens PM. Aminoglycosides: Nephrotoxicity. Antimicrob agents Chemother, 1999;13:1003–12.
   Google Scholar
• Mi-Song K, Cho M, Jo H, et al. Gold nanoparticle-based colorimetric detection of kanamycin using a DNA aptamer. Anal Biochem, 2011;415:175–81.
   PubMed Web of Science ®Google Scholar
• Modongo C, Pasipanodya JG, Zetola NM, et al. Antimicrob. Agents Chemother, 2015; 59:6337–43.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 2003;86:33–48.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols). J Control Release, 2002;80:129–44.
   PubMed Web of Science ®Google Scholar
• Mustafa S, Devi VK. Liquid chromatographic assay for the analysis of kanamycin sulphate nanoparticles in rat after intramuscular administration: Application to a pharmacokinetic study. J App Pharm Sci, 2016;6:57–66.
   Google Scholar
• Mustafa S, Pai RS, Singh G, et al. Nanocarrier-based interventions for the management of MDR/XDR-TB. J Drug Target, 2015;23:287–304.
   PubMed Web of Science ®Google Scholar
• Oberdorster G, Ferin J, Gelein R, et al. Role of the alveolar macrophage in lung injury: studies with ultrafine particles. Environ Health Perspect, 1992;97:193–9.
   PubMed Web of Science ®Google Scholar
• Peloquin CA, Berning SE, Nitta AT, et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis, 2004;38:1538–44.
   PubMed Web of Science ®Google Scholar
• Q1A(R2). (2003). Stability testing of new drug substances and products.
   Google Scholar
• Qian X, Dong H, Hu X, et al. Analysis of the interferences in quantitation of a site-specifically PEGylated exendin-4 analog by the Bradford method. Anal Biochem, 2014;465:50–2.
   PubMed Web of Science ®Google Scholar
• Saraya S, Kanta J, Sarisuta N, et al. Development of guava extract chewable tablets for anticariogenic activity against Streptococcus mutans. J Pharm Sci, 2008;35:18–23.
   Google Scholar
• Semete B, Booysen L, Kalombo L, et al. Effects of protein binding on the biodistribution of PEGylated PLGA nanoparticles post oral administration. Int J Pharm, 2012;424:115–20.
   PubMed Web of Science ®Google Scholar
• United States Pharmacopoeia. (2011).USP, USP 34, NF 29, The United States Pharmacopoeia and The National Formulary. Rockwille, MD: The United States Pharmacopoeial Convention; 20852.
   Google Scholar
• Varshosaz J, Ghaffari S, Mirshojaei SF. Biodistribution of amikacin solid lipid nanoparticles after pulmonary delivery. Biomed Res Int, 2013;2013:136859.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Lee SH, Feng SS. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials, 2007;28:1889–99.
   PubMed Web of Science ®Google Scholar
• Zolnik BS, Burgess DJ. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres. J Control Release, 2008;21:137–45.
   Web of Science ®Google Scholar